SCHEMBL7180322

SCHEMBL7180322

CC(CC(=O)c1cccs1)C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.72
HPGD P15428 5/20 0.72
NPC1 O15118 3/20 0.72
RAB9A P51151 3/20 0.72
SMN1; SMN2 Q16637 2/20 0.72
POLB P06746 2/20 0.62
LMNA P02545 5/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
GSK3B P49841 1/20 0.53
ERCC5 P28715 1/20 0.53
FEN1 P39748 1/20 0.53
DAO P14920 1/20 0.50
CYP2C9 P11712 2/20 0.49
KDM4E B2RXH2 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352557 0.85 RAB9A (0.70) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL3183222 0.84 ALDH1A1 (0.79) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL668302 0.83 ALDH1A1 (0.62) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL18906081 0.81 ALDH1A1 (0.87) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL23804626 0.81 HPGD (0.64) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL13058838 0.81 POLB (0.64) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL3235289 0.81 ALDH1A1 (0.74) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL7180515 0.80 ALDH1A1 (0.63) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL29119982 0.80 ALDH1A1 (0.50) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL27643228 0.80 HPGD (0.63) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1369410-A1 Process for the stereoselective reduction of derivatives of 4-aryl-4-oxobutyric acid BAYER AG (DE) 2003-12-10 EP claimed
EP-1369410-A1 Process for the stereoselective reduction of derivatives of 4-aryl-4-oxobutyric acid BAYER AG (DE) 2003-12-10 EP disclosed
US-4342690-A HHYPOTENSIVE AGE TS AMERICAN CYANAMID COMPANY (US) 1982-08-03 US disclosed
US-4342689-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1982-08-03 US disclosed
US-4342691-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1982-08-03 US disclosed
US-4299769-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1981-11-10 US disclosed